L’Agence américaine des produits alimentaires et médicamenteux (FDA) accorde la désignation de thérapie Breakthrough aux comprimés sublinguaux de sanbexine

Posted on by

NANJING, Chine, 16 septembre 2024 /PRNewswire/ — Le 2 septembre 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) a annoncé que comprimés sublinguaux de sanbexine (comprimés sublinguaux édaravone et dexborneol), un médicament innovant contre les accidents vasculaires cérébraux, a reçu…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.